Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy

Hepatocellular carcinoma (HCC) has been known as the second common leading cancer worldwide, as it responds poorly to both chemotherapy and medication. Triptolide (TP), a diterpenoid triepoxide, is a promising treatment agent for its effective anticancer effect on multiple cancers including HCC. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ling, Wang, Zhenjie, Mo, Zhuomao, Zou, Binhua, Yang, Yuanyuan, Sun, Rui, Ma, Wen, Yu, Meng, Zhang, Shijun, Yu, Zhiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343191/
https://www.ncbi.nlm.nih.gov/pubmed/34386334
http://dx.doi.org/10.1016/j.apsb.2021.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343191/
https://www.ncbi.nlm.nih.gov/pubmed/34386334
http://dx.doi.org/10.1016/j.apsb.2021.02.001

Ejemplares similares